Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study

por Lepola, Ulla, Hefting, Nanco, Zhang, Doris, Hobart, Mary
Publicado 2018

Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia

por Ivkovic, Jelena, Lindsten, Annika, George, Vinu, Eriksson, Hans, Hobart, Mary
Publicado 2019

Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale

por Hobart, Mary, Zhang, Peter, Weiss, Catherine, Meehan, Stine Rasmussen, Eriksson, Hans
Publicado 2018

Effect of Brexpiprazole on Prolactin and Sexual Functioning: An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder

por Clayton, Anita H., Ivkovic, Jelena, Chen, Dalei, George, Vinu, Hobart, Mary
Publicado 2020

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia

por Forbes, Andy, Hobart, Mary, Ouyang, John, Shi, Lily, Pfister, Stephanie, Hakala, Mika
Publicado 2018

Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies

por Marder, Stephen R, Meehan, Stine R, Weiss, Catherine, Chen, Dalei, Hobart, Mary, Hefting, Nanco
Publicado 2021

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

por Weiller, Emmanuelle, Weiss, Catherine, Watling, Christopher P, Edge, Christopher, Hobart, Mary, Eriksson, Hans, Fava, Maurizio
Publicado 2017

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

por Hobart, Mary, Zhang, Peter, Skuban, Aleksandar, Brewer, Claudette, Hefting, Nanco, Sanchez, Raymond, McQuade, Robert D.
Publicado 2019

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial

por Lee, Daniel, Slomkowski, Mary, Hefting, Nanco, Chen, Dalei, Larsen, Klaus Groes, Kohegyi, Eva, Hobart, Mary, Cummings, Jeffrey L., Grossberg, George T.
Publicado 2023

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

por Wigal, Sharon B, Wigal, Tim, Hobart, Mary, Madera, Jessica J, Baker, Ross A, Kohegyi, Eva, McKinney, Anthony, Wilens, Timothy E
Publicado 2020

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blin...

por Adler, Lenard A., Adams, Julie, Madera-McDonough, Jessica, Kohegyi, Eva, Hobart, Mary, Chang, Denise, Angelicola, Mark, McQuade, Robert, Liebowitz, Michael
Publicado 2022

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

por Fleischhacker, W. Wolfgang, Hobart, Mary, Ouyang, John, Forbes, Andy, Pfister, Stephanie, McQuade, Robert D., Carson, William H., Sanchez, Raymond, Nyilas, Margareta, Weiller, Emmanuelle
Publicado 2016